![](https://investorshub.advfn.com/uicon/792403.png?cb=1632160976)
Monday, March 07, 2022 3:38:45 PM
18:00
IPF Immune: have partnered with NPI for sales, marketing, logistics, regulatory compliance.
"We will be launching IPF Immune across multiple big and small retail chains, online platforms, in March 2022. Our production has been completed in Europe, and we are ready with our marketing campaigns. We have listened to the community. We will be launching a website dedicated to IPF Immune. The plan is also to go forward with TV commercials and reaching out to the community as such. Fortunately, the feedback that we receive from patients who receive pepsin fragment has been phenomenal. Patients have really benefited from this pepsin fragment. So what we have done, this dedicated website that we have, will have the option of leaving testimonials, reviews, and also have the options of buying it directly from the website."
Still 18 trading days left in March to make good on these claims or be transparent on what missed.
I edit too much! Refresh any of my posts within the first few minutes to get silly little updates and clarifications. :)
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM